Author

S. Aluri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

A. Verma· 2 shared K. Pradhan· 2 shared A. Aboumohamed· 1 shared A. K. Verma· 1 shared A. Pellagatti· 1 shared A. Shastri· 1 shared A. Sridharan· 1 shared A. Tischer· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Verma

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Iron Chelation Improves Ineffective Erythropoiesis and Iron Overload in Myelodysplastic Syndrome Mice

W. An, M. Feola, S. Aluri, M. Ruiz-Martinez, A. Sridharan, M. Levy, E. Fibach, X. Zhu, A. K. Verma, Y. Ginzburg

This study shows that iron chelation with deferiprone improves ineffective erythropoiesis and iron overload in MDS mice by normalizing iron metabolism and reducing oxidative stress.

bioRxiv · Oct 5, 2022Pathology

Activation of targetable inflammatory immune signaling is seen in Myelodysplastic Syndromes with SF3B1 mutations

G. Choudhary, A. Pellagatti, B. Agianian, M. Smith, T. D. Bhagat, S. Gordon-Mitchell, S. Pandey, N. Shah, S. Aluri, L. Schwartz, V. Steeples, R. Booher, M. Ramachandra, M. Samson, M. Carbajal, , A. Verma

This study identifies a longer, oncogenic IRAK4 isoform caused by SF3B1 mutations in MDS/AML, which is targetable by IRAK4 inhibition.

bioRxiv · Mar 9, 2022Cancer Biology

Methylation of Dual Specificity Phosphatase 4 Controls Cell Differentiation

H. Su, M. Jiang, C. Senevirathne, S. Aluri, T. Zhang, H. Guo, J. Xavier-Ferrucio, S. Jin, N.-T. Tran, S.-M. Liu, C.-W. Sun, Y. Zhu, Q. Zhao, Y. Chen, L. Cable, , X. Zhao

This study identifies PRMT1-mediated methylation of DUSP4 as a regulator of p38 MAPK activity, influencing megakaryocyte differentiation and thrombocytopenia in myelodysplastic syndromes.

bioRxiv · Dec 16, 2020Cell Biology

Functional succinate dehydrogenase deficiency and loss of ascorbic acid transporter SLC23A1 are pathognomonic adverse features of clear cell renal cancer

R. K. Aggarwal, Y. Zou, R. A. Luchtel, K. Pradhan, N. Ashai, N. Ramachandra, J. Albanese, J.-i. Yang, X. Wang, S. Aluri, S. Gordon, V. Machha, A. Tischer, A. Aboumohamed, B. A. Gartrell, , N. Shenoy

This paper identifies functional succinate dehydrogenase deficiency and loss of SLC23A1 as common adverse features in clear cell renal cell carcinoma, with implications for diagnosis and treatment.

bioRxiv · Jul 5, 2020Cancer Biology